Clinical Trials Logo
  1. Home
  2. Bronchospasm
  3. NCT00400660

A First Time In Human Study To Assess The Compound GSK615915

Bronchospasm Clinical Trial

Official title:
First Time in Human, Single Dose and Repeat Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK615915

Clinical Trial Summary

GSK615915A is being developed as a novel surfactant for use in the formulation of GSK's future generation of Metered Dose Inhalers (MDIs). A surfactant in a MDI would provide a more stable drug suspension, this in turn will produce a consistent dose of drug being delivered with each puff.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00400660
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date November 23, 2005
Completion date July 3, 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT05025709 - Bronchospasm During Anesthetic Induction: Study of Clinical Characteristics and Treatments Administered According to Etiology
Recruiting NCT05555134 - INHALATION CHAMBER MANAGEMENT IN PEDIATRICS: EFFICACY OF AN EDUCATIONAL INTERVENTION IN PATIENTS DIAGNOSED WITH BRONCHOSPASM AND THEIR FAMILY CAREGIVERS. Phase 1
Completed NCT03064659 - Driving Pressure And EFL in Adult Cardiac Surgery N/A
Recruiting NCT02090205 - Mechanical Ventilation During Cardiac Surgery N/A
Completed NCT05360810 - Wei Nasal Jet Tube vs Gastro Laryngeal Tube in Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT05783050 - Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients N/A
Recruiting NCT01488643 - Observational Study on Obese Patients During General Anesthesia N/A
Completed NCT03000413 - Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial Phase 2/Phase 3
Completed NCT02779595 - Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery N/A
Completed NCT01189396 - Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 Phase 2
Completed NCT01174732 - Dose-Ranging Study of A006 DPI, in Adult Asthma Patients Phase 2
Completed NCT01156701 - Prophylactic Efficacy of Relenza Against Influenza A and B N/A
Completed NCT00806455 - Exercise-Induced Bronchospasm in Cystic Fibrosis N/A
Completed NCT02419196 - Perioperative Change of Regional Ventilation During Spontaneous Breathing N/A
Completed NCT04373499 - Virtual Teach-to-Goal Education vs. Brief Education for Children N/A
Terminated NCT00634829 - Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction Phase 3
Completed NCT00118716 - A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise Phase 4
Completed NCT00118690 - A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise Phase 4
Terminated NCT03962725 - Avoiding Neuromuscular Blockers to Reduce Complications Phase 4
Completed NCT01188577 - Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics Phase 1/Phase 2